Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract

Applied and Environmental Microbiology

Volumn 80, Issue 3, 2014, Pages 928-934

  Kaci, Ghalia ^a   Goudercourt, Denise ^b,c,d   Dennin, Véronique ^b,c,d   Pot, Bruno ^b,c,d   Doré, Joël ^a   Ehrlich, S Dusko ^a   Renault, Pierre ^a   Blottière, Hervé M ^a   Daniel, Catherine ^b,c,d   Delorme, Christine ^a  

^a UMR1319 MICALIS   (France)

^b INSERM U1019   (France)

^c UNIV LILLE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORIES; DIGESTIVE TRACT; HUMAN PERIPHERAL BLOOD; IN-VITRO; INFLAMMATORY RESPONSE; INTESTINAL EPITHELIAL CELLS; MOUSE MODELS; ORAL CAVITY;

STRAIN;

BACTERIA;

BACTERIUM; BLOOD; DIGESTIVE SYSTEM; DISEASE TREATMENT; HOMEOSTASIS; HOMINID; IMMUNE SYSTEM; INHIBITION; MEDICINE; MICROBIOLOGY; RODENT;

ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL; ARTICLE; COLITIS; DISEASE MODEL; DRUG ANTAGONISM; EPITHELIUM CELL; GASTROINTESTINAL TRACT; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; MOUSE; MOUTH; PATHOLOGY; PHYSIOLOGY; STREPTOCOCCUS; SYMBIOSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GASTROINTESTINAL TRACT; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MOUTH; NF-KAPPA B; STREPTOCOCCUS; SYMBIOSIS;

EID: 84892966283     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03133-13     Document Type: Article

References (44)

1. Artis D. 2008. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8:411-420. http://dx.doi.org/10.1038/nri2316.
2. Yoon SS, Sun J. 2011. Probiotics, nuclear receptor signaling, and antiinflammatory pathways. Gastroenterol. Res. Pract. 2011:971938. http://dx .doi.org/10.1155/2011/971938.
3. Wan F, Lenardo MJ. 2010. The nuclear signaling of NF-kB: current knowledge, new insights, and future perspectives. Cell Res. 20:24-33. http://dx.doi.org/10.1038/cr.2009.137.
4. Candela M, Perna F, Carnevali P, Vitali B, Ciati R, Gionchetti P, Rizzello F, Campieri M, Brigidi P. 2008. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 125:286-292. http://dx .doi.org/10.1016/j.ijfoodmicro.2008.04.012.
5. Lin PW, Myers LE, Ray L, Song SC, Nasr TR, Berardinelli AJ, Kundu K, Murthy N, Hansen JM, Neish AS. 2009. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic. Biol. Med. 47:1205-1211. http://dx.doi.org/10.1016/j .freeradbiomed.2009.07.033.
6. Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppee JY, Bourdet-Sicard R, Sansonetti PJ, Pedron T. 2006. Antiinflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 176:1228-1237.
7. Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, Dewulf J, Brassart D, Mercenier A, Pot B. 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. 13:236-243.
8. Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B. 2006. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl. Environ. Microbiol. 72:5799-5805. http://dx .doi.org/10.1128/AEM.00109-06.
9. Heuvelin E, Lebreton C, Grangette C, Pot B, Cerf-Bensussan N, Heyman M. 2009. Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors. PLoS One 4:e5184. http://dx .doi.org/10.1371/journal.pone.0005184.
10. Kim SW, Kim HM, Yang KM, Kim SA, Kim SK, An MJ, Park JJ, Lee SK, Kim TI, Kim WH, Cheon JH. 2010. Bifidobacterium lactis inhibits NF-kB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. Inflamm. Bowel Dis. 16:1514-1525. http://dx.doi .org/10.1002/ibd.21262.
11. Zoumpopoulou G, Foligne B, Christodoulou K, Grangette C, Pot B, Tsakalidou E. 2008. Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models. Int. J. Food Microbiol. 121:18-26. http://dx.doi.org/10.1016/j.ijfoodmicro .2007.10.013.
12. Rauch M, Lynch S. 2012. The potential for probiotic manipulation of the gastrointestinal microbiome. Curr. Opin. Biotechnol. 23:192-201. http: //dx.doi.org/10.1016/j.copbio.2011.11.004.
13. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. 2005. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100: 1539-1546. http://dx.doi.org/10.1111/j.1572-0241.2005.41794.x.
14. Gionchetti P, Rizzello F, Morselli C, Poggioli G, Tambasco R, Calabrese C, Brigidi P, Vitali B, Straforini G, Campieri M. 2007. High-dose probiotics for the treatment of active pouchitis. Dis. Colon Rectum 50: 2075-2082. http://dx.doi.org/10.1007/s10350-007-9068-4.
15. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M, Kamm MA. 2004. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53:108-114. http://dx.doi.org/10.1136 /gut.53.1.108.
16. Petrof EO. 2009. Probiotics and gastrointestinal disease: clinical evidence and basic science. Antiinflamm. Antiallergy Agents Med. Chem. 8:260- 269. http://dx.doi.org/10.2174/187152309789151977.
17. Hakalehto E, Vilpponen-Salmela T, Kinnunen K, von Wright A. 2011. Lactic acid bacteria enriched from human gastric biopsies. ISRN Gastroenterol. 2011:109183. http://dx.doi.org/10.5402/2011/109183.
18. Wang M, Ahrne S, Jeppsson B, Molin G. 2005. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol. Ecol. 54:219-231. http://dx.doi .org/10.1016/j.femsec.2005.03.012.
19. Tanzer JM, Kurasz AB, Clive J. 1985. Competitive displacement of mutans streptococci and inhibition of tooth decay by Streptococcus salivarius TOVE-R. Infect. Immun. 48:44-50.
20. Sliepen I, Van Essche M, Loozen G, Van Eldere J, Quirynen M, Teughels W. 2009. Interference with Aggregatibacter actinomycetemcomitans: colonization of epithelial cells under hydrodynamic conditions. Oral Microbiol. Immunol. 24:390-395. http://dx.doi.org/10.1111/j.1399-302X .2009.00531.x.
21. Van Hoogmoed CG, Geertsema-Doornbusch GI, Teughels W, Quirynen M, Busscher HJ, Van der Mei HC. 2008. Reduction of periodontal pathogens adhesion by antagonistic strains. Oral Microbiol. Immunol. 23:43-48. http://dx.doi.org/10.1111/j.1399-302X.2007.00388.x.
22. Birri DJ, Brede DA, Nes IF. 2012. Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant. Appl. Environ. Microbiol. 78:402-410. http://dx .doi.org/10.1128/AEM.06588-11.
23. Santagati M, Scillato M, Patane F, Aiello C, Stefani S. 2012. Bacteriocinproducing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol. Med. Microbiol. 65:23-31. http://dx.doi.org/10.1111/j .1574-695X.2012.00928.x.
24. Tagg JR, Dierksen KP. 2003. Bacterial replacement therapy: adapting 'germ warfare' to infection prevention. Trends Biotechnol. 21:217-223. http://dx.doi.org/10.1016/S0167-7799(03)00085-4.
25. Frick JS, Fink K, Kahl F, Niemiec MJ, Quitadamo M, Schenk K, Autenrieth IB. 2007. Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics. Infect. Immun. 75:3490-3497. http://dx.doi.org/10.1128/IAI.00119-07.
26. Sliepen I, Van Damme J, Van Essche M, Loozen G, Quirynen M, Teughels W. 2009. Microbial interactions influence inflammatory host cell responses. J. Dent. Res. 88:1026-1030. http://dx.doi.org/10.1177 /0022034509347296.
27. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, Yu LL, Pistolic J, Falsafi R, Tagg J, Hancock RE. 2008. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect. Immun. 76:4163-4175. http://dx.doi.org/10.1128 /IAI.00188-08.
28. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, Karp M, Mora D. 2010. Oral bacteria as potential probiotics for the pharyngeal mucosa. Appl. Environ. Microbiol. 76:3948-3958. http://dx.doi.org/10 .1128/AEM.00109-10.
29. Kaci G, Lakhdari O, Dore J, Ehrlich SD, Renault P, Blottiere HM, Delorme C. 2011. Inhibition of the NF-kB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Appl. Environ. Microbiol. 77:4681-4684. http://dx.doi.org/10.1128/AEM.03021-10.
30. Araujo R, Rodrigues AG, Pina-Vaz C. 2004. A fast, practical and reproducible procedure for the standardization of the cell density of an Aspergillus suspension. J. Med. Microbiol. 53:783-786. http://dx.doi.org/10 .1099/jmm.0.05425-0.
31. Foligne B, Nutten S, Steidler L, Dennin V, Goudercourt D, Mercenier A, Pot B. 2006. Recommendations for improved use of the murine TNBSinduced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects. Dig. Dis. Sci. 51:390- 400. http://dx.doi.org/10.1007/s10620-006-3143-x.
32. Ameho CK, Adjei AA, Harrison EK, Takeshita K, Morioka T, Arakaki Y, Ito E, Suzuki I, Kulkarni AD, Kawajiri A, Yamamoto S. 1997. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 41:487-493. http://dx.doi.org/10.1136 /gut.41.4.487.
33. Bradley PP, Priebat DA, Christensen RD, Rothstein G. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Investig. Dermatol. 78:206-209. http://dx.doi.org /10.1111/1523-1747.ep12506462.
34. Kekkonen RA, Kajasto E, Miettinen M, Veckman V, Korpela R, Julkunen I. 2008. Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. World J. Gastroenterol. 14:1192-1203. http://dx.doi.org/10.3748/wjg.14 .1192.
35. Ito M, Ohishi K, Yoshida Y, Okumura T, Sato T, Yokoi W, Sawada H. 2008. Preventive effect of Streptococcus thermophilus YIT 2001 on dextran sulfate sodium-induced colitis in mice. Biosci. Biotechnol. Biochem. 72: 2543-2547. http://dx.doi.org/10.1271/bbb.80240.
36. Ogita T, Nakashima M, Morita H, Saito Y, Suzuki T, Tanabe S. 2011. Streptococcus thermophilus ST28 ameliorates colitis in mice partially by suppression of inflammatory Th17 cells. J. Biomed. Biotechnol. 2011: 378417. http://dx.doi.org/10.1155/2011/378417.
37. Foligne B, Dewulf J, Vandekerckove P, Pignede G, Pot B. 2010. Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice. World J. Gastroenterol. 16:2134-2145. http://dx.doi.org/10.3748/wjg.v16.i17.2134.
38. Adams CA. 2010. The probiotic paradox: live and dead cells are biological response modifiers. Nutr. Res. Rev. 23:37-46. http://dx.doi.org/10.1017 /S0954422410000090.
39. Li N, Russell WM, Douglas-Escobar M, Hauser N, Lopez M, Neu J. 2009. Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy- fed infant rats. Pediatr. Res. 66:203-207. http://dx.doi.org/10.1203 /PDR.0b013e3181aabd4f.
40. Lin WH, Yu B, Lin CK, Hwang WZ, Tsen HY. 2007. Immune effect of heat-killed multistrain of Lactobacillus acidophilus against Salmonella typhimurium invasion to mice. J. Appl. Microbiol. 102:22-31. http://dx.doi .org/10.1111/j.1365-2672.2006.03073.x.
41. Zhang L, Li N, Caicedo R, Neu J. 2005. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin- 8 production in Caco-2 cells. J. Nutr. 135:1752-1756.
42. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottiere HM, Dore J, Marteau P, Seksik P, Langella P. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 105:16731-16736. http://dx.doi.org/10.1073/pnas.0804812105.
43. Delorme C, Poyart C, Ehrlich SD, Renault P. 2007. Extent of horizontal gene transfer in evolution of streptococci of the salivarius group. J. Bacteriol. 189:1330-1341. http://dx.doi.org/10.1128/JB.01058-06.
44. Gasson MJ. 1983. Plasmid complements of Streptococcus lactisNCDO712 and other lactic streptococci after protoplast-induced curing. J. Bacteriol. 154:1-9.